Discover the complete record of transactions filed by Hoffman William, Director. Officer active across 1 companies, notably Inari Medical, Inc.. Aggregated, 44 reports have been published. Total volume traded: €22.4m. The latest transaction was disclosed on 6 June 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
25 of 44 declarations
William Hoffman is a U.S. medical device executive most closely associated with Inari Medical, Inc., where he served as Chief Executive Officer and President from February 2015 through December 2022 and continues to serve as a member of the Board of Directors. His career reflects a strong track record in commercial leadership, operating execution, and scaling healthcare technology businesses. Prior to joining Inari, Hoffman was Chief Executive Officer of Visualase, Inc., a private company focused on MRI-guided laser systems, until its acquisition by Medtronic in July 2014. He also served as Chief Operating Officer of Rubicor Medical, Inc., a private medical technology company focused on minimally invasive breast biopsy and lumpectomy solutions. Earlier in his career, he worked at FoxHollow Technologies, Inc., where he held successive sales leadership roles as Director of Sales and then Vice President of Sales for a company developing medical devices used to treat peripheral artery disease. This progression highlights a background rooted in revenue generation, field organization leadership, and the growth of innovative medtech businesses. At Inari, Hoffman helped build and expand a company centered on the treatment of venous disease and other vascular conditions. During his tenure, the company strengthened its commercial footprint, scaled operations, and emphasized disciplined execution and governance. His profile suggests particular expertise in bringing medical technologies to market, leading fast-growing organizations, and guiding private companies through major strategic transitions, including acquisition and public-company growth.